Pharmacogenetics: from bench to byte
JJ Swen, I Wilting, AL De Goede… - Clinical …, 2008 - Wiley Online Library
Despite initial enthusiasm, 1, 2, 3 the use of pharmacogenetics has remained limited to
investigation in only a few clinical fields such as oncology and psychiatry. 4, 5, 6, 7, 8 The …
investigation in only a few clinical fields such as oncology and psychiatry. 4, 5, 6, 7, 8 The …
Rapid metabolizer genotype of CYP2C19 is a risk factor of being refractory to proton pump inhibitor therapy for reflux esophagitis
H Ichikawa, M Sugimoto, K Sugimoto… - Journal of …, 2016 - Wiley Online Library
Abstract Background: Proton pump inhibitors (PPIs) are mainly metabolized by cytochrome
P450 2C19 (CYP2C19) and used as the first‐line therapy for gastroesophageal reflux …
P450 2C19 (CYP2C19) and used as the first‐line therapy for gastroesophageal reflux …
Efficacies of genotypic resistance-guided vs empirical therapy for refractory Helicobacter pylori infection
Background & Aims We aimed to compare the efficacy of genotypic resistance–guided
therapy vs empirical therapy for eradication of refractory Helicobacter pylori infection in …
therapy vs empirical therapy for eradication of refractory Helicobacter pylori infection in …
[HTML][HTML] Intravenous proton pump inhibitors for peptic ulcer bleeding: Clinical benefits and limits
HC Cheng, BS Sheu - World Journal of Gastrointestinal …, 2011 - ncbi.nlm.nih.gov
Peptic ulcer bleeding is a common disease and recurrent bleeding is an independent risk
factor of mortality. Infusion with proton pump inhibitors (PPIs) prevents recurrent bleeding …
factor of mortality. Infusion with proton pump inhibitors (PPIs) prevents recurrent bleeding …
Histamine2-receptor antagonists are an alternative to proton pump inhibitor in patients receiving clopidogrel
BACKGROUND & AIMS: Previous observational studies reported that concomitant use of
clopidogrel and proton pump inhibitors (PPIs) in patients with prior acute coronary syndrome …
clopidogrel and proton pump inhibitors (PPIs) in patients with prior acute coronary syndrome …
[HTML][HTML] Tailored susceptibility-guided therapy via gastric juice PCR for the first-line H. pylori eradication, a randomized controlled trial
MS Hsieh, FC Kuo, MC Wu, JW Wang, CJ Liu… - Journal of the Formosan …, 2022 - Elsevier
Background/Purpose Clarithromycin-based standard triple therapy is still commonly adopted
by 81.4% of physicians in real-world practice but yields low eradication rates. Therefore, we …
by 81.4% of physicians in real-world practice but yields low eradication rates. Therefore, we …
14 day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter …
JM Liou, CC Chen, YJ Fang, PY Chen… - Journal of …, 2018 - academic.oup.com
Background Whether extending the treatment length and the use of high-dose
esomeprazole may optimize the efficacy of Helicobacter pylori eradication remains …
esomeprazole may optimize the efficacy of Helicobacter pylori eradication remains …
Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome
FY Hsiao, CD Mullins, YW Wen… - … and drug safety, 2011 - Wiley Online Library
Background There is conflicting evidence regarding the potential interaction between
clopidogrel and proton pump inhibitors (PPIs), with observational studies suggesting an …
clopidogrel and proton pump inhibitors (PPIs), with observational studies suggesting an …
Performance of narrow band imaging and magnification endoscopy in the prediction of therapeutic response in patients with gastroesophageal reflux disease
PH Tseng, CC Chen, HM Chiu, WC Liao… - Journal of clinical …, 2011 - journals.lww.com
Background Imaging-enhanced endoscopy enhances the contrast of the mucosal surface
and helps in the diagnosis of gastroesophageal reflux disease. However, whether the …
and helps in the diagnosis of gastroesophageal reflux disease. However, whether the …
[HTML][HTML] Consensus of gastroesophageal reflux disease in Taiwan with endoscopy-based approach covered by National Health Insurance
Background and aims Gastroesophageal reflux disease (GERD) is emerging as a clinical
complication in the Orient. The consensus comprises recommendations to GERD control …
complication in the Orient. The consensus comprises recommendations to GERD control …